CLINICAL_TRIALS
trial_result
· 2022-07-19
Clinical Trial Update: An Open-label, Randomized, 2-Period, Crossover, Pharmacokinetics Study [Phase 2]
Summary
Phase 2 open-label randomized crossover pharmacokinetics study completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Lupin Research Inc | Conditions: Pregnancy Prevention | Phase 2 | Status: COMPLETED